million
peopl
infect
worldwid
hepat
c
viru
hcv
becom
global
health
problem
major
caus
viral
hepat
persist
infect
occur
infect
patient
follow
seriou
complic
inflamm
insulin
resist
steatosi
fibrosi
hepatocellular
carcinoma
patholog
associ
chronic
hcv
infect
initi
thought
relat
immun
respons
view
direct
cytopath
effect
cpe
viral
infect
cell
also
contribut
substanti
liver
injuri
cellular
mechan
hcv
replic
might
mediat
liver
injuri
entir
clear
et
al
investig
cellular
effect
hcv
infect
replic
use
cell
cultur
system
found
infect
cell
contain
substanti
cpe
character
massiv
apoptot
cell
death
much
express
sever
endoplasm
reticulum
er
protein
moreov
transfect
cell
death
occur
cell
infect
intracellular
hcv
rna
reach
maximum
level
mishima
et
al
identifi
mutant
virus
individu
signatur
substitut
enhanc
viru
replic
protein
express
earlyacut
stage
infect
final
led
massiv
cell
death
addit
also
found
cytopathogen
close
associ
level
intracellular
viral
replic
determin
certain
amino
acid
substitut
region
unfortun
studi
base
recombin
viru
model
liver
cancer
cell
inevit
metabol
differ
exist
hepatoma
cell
line
quiescent
primari
hepatocyt
appar
cell
line
fulli
recapitul
aspect
hcv
infect
liver
host
respons
play
import
role
determin
viral
persist
clearanc
previou
studi
establish
infect
system
base
human
fetal
liver
stem
cell
hflsc
could
complet
exhibit
entir
hcv
bbhcv
life
cycl
includ
transmiss
viru
effici
cell
process
model
build
found
mitochondri
alter
er
stress
contribut
lot
better
understand
hcv
pathogenesi
provid
insight
hcv
life
cycl
therefor
focus
use
cell
model
investig
effect
hcv
infect
cell
vitro
serum
sampl
obtain
patient
chronic
hcv
infect
treat
peke
union
medic
colleg
hospit
inform
consent
obtain
patient
patient
receiv
antivir
therapi
prior
studi
donor
serolog
screen
syphili
toxoplasmosi
rubella
hepat
b
human
immunodefici
viru
cytomegaloviru
parvoviru
well
herp
simplex
type
donor
inform
shown
supplementari
materi
tabl
hflsc
infect
bbhcv
accord
previous
describ
protocol
brief
sera
supernat
contain
progeni
viru
filter
polar
filter
infect
hflsc
grown
densiti
plate
genom
copi
gc
ml
bbhcv
gcsml
progeni
viru
ml
cultur
media
ad
well
incub
h
cell
rins
final
wash
collect
analyz
use
confirm
absenc
hcv
rna
ad
ml
fb
cultur
supernat
collect
everi
day
cultur
period
store
detect
quantif
viru
hflsc
supernat
infect
cell
accord
previous
describ
protocol
detail
protocol
present
supplementari
materi
supplementari
materi
method
hflsc
fix
incub
paraformaldehyd
pb
ph
h
cell
collect
centrifug
cell
pellet
dehydr
grade
seri
ethanol
solut
use
automat
freez
substitut
system
af
leica
vienna
austria
embed
london
resin
gold
lr
gold
electron
microscopi
scienc
basingstok
uk
resin
allow
polymer
uv
light
h
section
cut
block
incub
bsa
sigma
st
loui
mo
usa
pb
incub
antibodi
describ
dilut
pb
supplement
bsa
section
wash
incub
appropri
volum
nm
gold
secondari
antibodi
british
biocel
intern
cardiff
uk
dilut
pb
supplement
bsa
section
cut
stain
uranyl
acet
lead
citrat
place
em
grid
coat
collodion
examin
protein
prepar
use
qproteom
mammalian
protein
prep
kit
column
qiagen
hilden
germani
total
protein
cell
cultur
media
separ
sodium
dodecyl
gel
electrophoresi
transfer
pvdf
membran
blot
block
nonfat
dri
milk
buffer
salin
ph
contain
tbst
probe
primari
antibodi
h
western
blot
perform
use
follow
antibodi
core
santa
cruz
biotechnolog
inc
dalla
tx
usa
santa
cruz
biotechnolog
inc
santa
cruz
biotechnolog
inc
santa
cruz
biotechnolog
inc
protein
santa
cruz
biotechnolog
inc
biolegend
san
diego
ca
usa
cst
beverli
usa
cst
cst
cst
cst
cst
cst
protein
cst
extens
wash
blot
incub
secondari
antibodi
conjug
horseradish
peroxidas
h
wash
four
time
tbst
protein
band
detect
use
enhanc
chemiluminesc
reagent
film
equal
amount
mitochondri
cytosol
protein
mg
prepar
previous
describ
minczuk
et
al
separ
transfer
pvdf
membran
immunodetect
cytochrom
c
monoclon
antibodi
pharmingen
san
diego
ca
usa
actin
polyclon
antibodi
santa
cruz
biotechnolog
inc
use
primari
antibodi
mitochondri
fraction
puriti
verifi
immunoblot
antibodi
specif
human
cytochrom
oxidas
subunit
ii
cox
ii
molecular
probe
waltham
usa
measur
hcv
protein
level
surfac
hflsc
cell
block
bsa
sigma
min
prior
stain
progress
primari
secondari
antibodi
combin
immunofluoresc
process
cell
stain
propidium
iodid
pb
pass
facscalibur
flow
cytomet
bd
bioscienc
ca
usa
mous
abcam
cambridg
usa
rabbit
abcam
use
isotyp
control
experi
repeat
three
time
estim
percentag
cell
activ
bax
bbhcv
infect
hflsc
control
hflsc
indic
time
period
incub
rabbit
polyclon
santa
cruz
biotechnolog
inc
antibodi
cell
wash
three
time
pb
stain
texa
red
igg
antibodi
final
cell
wash
three
time
pb
analyz
use
flow
cytomet
estim
product
ro
bbhcv
infect
hflsc
indic
time
period
expos
mitosox
red
fluorochrom
specif
anion
superoxid
produc
inner
mitochondri
compart
invitrogen
grand
island
ny
usa
approxim
cell
trypsin
incub
mitosox
min
wash
twice
pb
resuspend
pb
cytofluorometr
analysi
perform
use
flow
cytomet
atp
level
examin
firefli
atp
assay
kit
beyotim
haimen
china
assay
conduct
accord
manufactur
instruct
brief
mitochondri
lysi
mitochondri
fraction
centrifug
g
min
supernat
remov
atp
assay
atp
reagent
ad
microwel
min
sampl
ad
mix
measur
use
synergi
ht
micropl
reader
atp
concentr
calcul
standard
curv
data
express
nmol
per
mg
protein
mitochondri
membran
potenti
determin
assay
kit
flow
cytometri
invitrogen
accord
manufactur
instruct
brief
cell
suspend
incub
mm
cccp
control
min
wash
ml
warm
pb
final
cell
resuspend
pb
analyz
flow
cytomet
use
nm
excit
experi
conduct
least
three
separ
experi
duplic
data
express
mean
sd
analyz
use
spss
window
version
spss
inc
chicago
il
usa
p
valu
consid
statist
signific
detail
assay
serum
characterist
primer
probe
sequenc
present
supplementari
materi
supplementari
materi
method
assess
electron
microscop
imag
determin
whether
cpe
exist
hflsc
contrast
control
section
er
linear
typic
cytoplasm
distribut
mitochondria
intact
crista
observ
figur
cell
section
infect
bbhcv
er
distent
mitochondri
swell
figur
c
supplementari
materi
figur
numer
doubl
membran
vesicl
dmv
presenc
discret
multivesicular
unit
featur
similar
observ
rna
virus
polioviru
coronaviru
figur
supplementari
materi
figur
howev
effect
could
observ
cell
expos
bbhcv
see
supplementari
materi
figur
indic
phenomena
definit
caus
activ
viral
replic
major
hflsc
infect
bbhcv
eventu
show
cell
death
cell
stain
dapi
nuclear
morpholog
variou
time
postinfect
cell
bbhcv
infect
h
postinfect
reveal
nuclear
shrinkag
featur
cellular
apoptosi
figur
order
assess
whether
infect
cell
involv
apoptot
process
perform
annexin
v
stain
flow
cytometri
analysi
found
level
annexin
v
posit
increas
extend
time
reach
peak
within
hflsc
h
postinfect
declin
h
postinfect
figur
c
supplementari
materi
figur
explor
role
er
stress
play
cell
apoptosi
express
er
protein
phosphoryl
assess
cell
overexpress
phosphoryl
strongli
suggest
bbhcv
infect
could
induc
er
stress
earli
cell
respons
figur
persist
er
stress
activ
apoptosi
signal
pathway
includ
induct
cebp
homolog
protein
chop
activ
caspas
figur
close
relat
cell
death
similar
annexin
v
protein
peak
h
h
postinfect
declin
h
postinfect
report
chop
overexpress
may
lead
bax
activ
transloc
cytosol
mitochondria
found
bax
activ
cluster
mitochondria
occur
bbhcv
infect
cell
h
postinfect
figur
decreas
h
postinfect
well
known
bax
activ
could
induc
mitochondri
membran
depolar
investig
effect
bbhcv
infect
mitochondri
membran
potenti
proport
cell
decreas
cell
much
higher
control
figur
supplementari
materi
figur
meanwhil
level
mitochondri
ro
intracellular
atp
display
similar
result
figur
cytochrom
c
associ
hcv
replic
could
releas
cytosol
cell
figur
final
sought
determin
whether
hcv
could
lead
activ
termin
caspas
use
antibodi
could
recogn
procaspas
cleav
activ
caspas
subunit
found
cleav
activ
subunit
h
postinfect
figur
result
demonstr
bbhcv
infect
could
definit
induc
advanc
apoptot
process
earli
stage
infect
apoptosi
protein
decreas
h
postinfect
major
cell
recov
show
appar
death
afterward
express
depend
protein
phosphoryl
statu
akt
infect
hflsc
investig
immunoblot
analysi
reveal
express
protein
xiap
long
form
cflip
markedli
activ
cell
h
post
infect
figur
meanwhil
phosphoryl
akt
increas
bbhcv
infect
cell
wherea
phosphoryl
level
significantli
alter
infect
bbhcv
figur
simultan
increas
express
tym
jund
ubd
mrna
whose
protein
function
relat
decreas
level
suppli
protect
effect
apoptosi
suggest
cell
counteract
activ
signal
pathway
figur
hcv
infect
induc
cpe
part
infect
process
whether
establish
infect
model
could
simul
undergo
cpe
similar
lesion
observ
hepat
patient
could
measur
model
success
present
cpe
vital
cell
cultur
system
could
contribut
understand
hcv
pathogenesi
system
cpe
induc
bbhcv
infect
includ
er
distent
mitochondri
swell
cell
vacuol
similar
cell
lesion
deriv
chronic
hcv
patient
mechan
pathogenesi
induc
bbhcv
infect
might
trace
back
apoptosi
hflsc
earli
stage
infect
time
go
apoptosi
would
gradual
inhibit
increas
express
activ
surviv
pathway
sequest
activ
disrupt
balanc
surviv
cell
infect
cell
inhibit
apoptosi
acceler
cycl
cell
apoptosi
regener
repair
result
hcv
infect
could
shorten
cell
death
cycl
give
rise
develop
cirrhosi
ultim
lead
hepatocellular
carcinogenesi
report
andor
signal
pathway
could
lead
upregul
subunit
locat
nuclei
could
caus
inhibit
respiratori
activ
depress
mitochondri
complex
along
uncoupl
mitochondri
oxid
phosphoryl
effici
data
also
provid
strong
demonstr
atp
product
increas
cell
infect
bbhcv
glycolyt
metabol
respons
might
respons
phenomenon
impair
mitochondri
oxid
phosphoryl
effici
addit
mitochondri
oxid
phosphoryl
impair
associ
oxid
stress
clearli
track
mitochondri
compart
ro
first
form
ro
trigger
permeabl
transit
pore
cytochrom
c
could
releas
diffus
cytosol
ultim
cytochrom
c
would
induc
apoptot
program
caus
subsequ
cell
damag
report
hepatocyt
injur
patient
high
serum
hcv
level
postliv
transplant
associ
cholestat
fibrosi
sever
form
hepat
em
hcv
liver
biopsi
show
hepatocyt
would
undergo
vacuol
lysi
membran
organel
degener
mitochondria
dilat
cytoplasm
reticulum
tubul
format
appreci
amount
larg
polymorph
secondari
phagosom
kasprzak
et
al
sum
data
nuclear
lesion
liver
biopsi
chronic
hcv
infect
involv
swell
alter
shape
hyperchromasia
disturb
nuclear
chromatin
structur
nuclear
lesion
alway
occur
cell
chang
rough
er
within
long
tubular
structur
branch
fibril
insid
cytoplasm
chang
includ
mitochondri
lesion
numer
lipid
vacuol
free
tubular
structur
highli
osmiophil
charact
similarli
et
al
studi
liver
biopsi
patient
chronic
hcv
infect
found
liver
biopsi
sampl
chronic
patient
show
ultrastructur
cell
damag
balloon
hepatocyt
dilat
er
mitochondria
observ
importantli
studi
shown
fibrosi
progress
vulner
coinfect
patient
hiv
monoinfect
patient
lead
increas
rate
cirrhosi
complic
loss
secondari
immun
hcv
could
provid
possibl
explan
higher
persist
rate
hcv
coinfect
patient
hiv
histolog
variant
liver
biopsi
specimen
coinfect
individu
might
due
direct
cytopath
activ
hcv
contrast
et
al
conduct
em
observ
cell
harbor
hcv
full
length
replicon
reveal
promin
cluster
mitochondria
perinuclear
region
within
hcv
infect
cell
dramat
loss
mitochondri
crista
compar
uninfect
cell
katz
et
al
attempt
gain
insight
mechan
cell
death
perform
microarray
experi
cell
infect
presenc
activ
cell
gene
strongli
indic
hcv
infect
associ
direct
cpe
wealth
publish
literatur
refer
experi
one
hcv
protein
could
induc
cytopathogen
cultur
hepatocyt
core
protein
report
effect
death
ligand
mediat
hepatocyt
apoptosi
hcv
envelop
protein
found
inhibit
apoptosi
induc
apoptosi
hepatoma
cell
line
perturb
apoptot
pathway
also
demonstr
nonstructur
protein
situat
suggest
hcv
could
induc
cell
damag
vivo
vitro
main
cpe
describ
previous
similar
observ
bbhcv
infect
hflsc
includ
er
distent
mitochondri
swell
cell
vacuol
model
expect
provid
power
tool
studi
cytolog
mechan
hcv
infect
vitro
explor
develop
cirrhosi
hepatocellular
carcinogenesi
author
contribut
articl
xg
complet
main
experi
draft
full
manuscript
dy
wll
complet
part
trial
hcv
detect
zq
zgq
complet
partial
experi
process
revis
manuscript
jwl
mj
conceiv
design
experi
contribut
edit
manuscript
supplementari
materi
onlin
supplementari
materi
method
supplementari
figur
legend
figur
bbhcv
induc
cytopathogen
hflsc
figur
hflsc
infect
bbhcv
harvest
indic
time
annexin
v
express
flow
cytometr
analysi
figur
hflsc
infect
bbhcv
harvest
indic
time
flow
cytometr
analysi
tabl
serum
characterist
rna
quantiti
infect
hflsc
tabl
primer
probe
use
studi
